Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from Observe Medical ASA ( (DE:OM50) ) is now available.
Observe Medical has secured significant tenders for its UnoMeter Safeti Plus product in the Nordic region, winning exclusive rights in Sweden’s largest region and non-exclusive rights in key Finnish markets, while also signing supply contracts in Denmark covering 60% of the market. These achievements, facilitated by distribution partner Vingmed, reinforce the product’s strong market position and potential for substantial annual revenue, highlighting its unmatched quality and clinical performance in the region.
More about Observe Medical ASA
Observe Medical is a Nordic medtech company headquartered in Oslo, Norway, that develops, markets, and sells innovative medical technology products globally. The company focuses on improving patient welfare, clinical data accuracy, and health economics through its expertise in sales and commercialization of products, primarily in urine measurement and ultrasound, alongside targeted mergers and acquisitions and distribution strategies.
Average Trading Volume: 136,737
Current Market Cap: NOK15.41M
For detailed information about OM50 stock, go to TipRanks’ Stock Analysis page.